株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の輸液システム市場:パイプライン分析、競争環境、2017年までの市場予測

Infusion Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

発行 GlobalData 商品コード 229713
出版日 ページ情報 英文 98 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
世界の輸液システム市場:パイプライン分析、競争環境、2017年までの市場予測 Infusion Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
出版日: 2012年02月20日 ページ情報: 英文 98 Pages
概要

当レポートでは、輸液システムの世界市場の最新動向と将来展望について分析し、全体的な市場構造・動向、部門別・国別の市場動向(2003〜2017年の市場収益の計測・予測など)、主要企業のプロファイル、各種製品のパイプライン評価、資本取引状況などの情報を取りまとめ、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

  • 市場の分類
  • 当レポートの構成

第3章 装置の概要

  • 携帯型輸液ポンプ
    • 使い捨て式携帯型ポンプ
    • 再利用式携帯型ポンプ
  • 埋め込み型輸液ポンプ
  • 輸液用使い捨てセット
  • シリンジポンプ
    • 自己調整鎮痛式(PCA)シリンジポンプ
    • 標準型シリンジポンプ
  • 容積ポンプ

第4章 世界市場の特徴

  • 市場収益実績値(全世界、2003〜2010年)
  • 市場収益予測値(全世界、2010〜2017年)
  • 主な傾向
    • 医療費償還過程と市場条件の改善による在宅輸液療法の発展が、輸液システム市場の成長を促進する
    • 米国FDA(食品医薬品局)による輸液システム関連リスク低減の促進策が、輸液システム市場のダイナミクスを変化させうる
  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因

第5章 部門別分析:市場収益(2003〜2017年)

  • 携帯型輸液ポンプ:市場収益実績値(全世界、2003〜2010年)
  • 携帯型輸液ポンプ:市場収益予測値(全世界、2010〜2017年)
  • 埋め込み型輸液ポンプ:市場収益実績値(全世界、2003〜2010年)
  • 埋め込み型輸液ポンプ:市場収益予測値(全世界、2010〜2017年)
  • シリンジポンプ:市場収益実績値(全世界、2003〜2010年)
  • シリンジポンプ:市場収益予測値(全世界、2010〜2017年)
  • 容積ポンプ:市場収益実績値(全世界、2003〜2010年)
  • 容積ポンプ:市場収益予測値(全世界、2010〜2017年)

第6章 各国市場の分析:市場収益(2003〜2017年)

  • 市場収益実績値(米国、2003〜2010年)
  • 市場収益予測値(米国、2010〜2017年)
  • 市場収益実績値(カナダ、2003〜2010年)
  • 市場収益予測値(カナダ、2010〜2017年)
  • 市場収益実績値(英国、2003〜2010年)
  • 市場収益予測値(英国、2010〜2017年)
  • 市場収益実績値(ドイツ、2003〜2010年)
  • 市場収益予測値(ドイツ、2010〜2017年)
  • 市場収益実績値(フランス、2003〜2010年)
  • 市場収益予測値(フランス、2010〜2017年)
  • 市場収益実績値(イタリア、2003〜2010年)
  • 市場収益予測値(イタリア、2010〜2017年)
  • 市場収益実績値(スペイン、2003〜2010年)
  • 市場収益予測値(スペイン、2010〜2017年)
  • 市場収益実績値(日本、2003〜2010年)
  • 市場収益予測値(日本、2010〜2017年)
  • 市場収益実績値(中国、2003〜2010年)
  • 市場収益予測値(中国、2010〜2017年)
  • 市場収益実績値(インド、2003〜2010年)
  • 市場収益予測値(インド、2010〜2017年)
  • 市場収益実績値(オーストラリア、2003〜2010年)
  • 市場収益予測値(オーストラリア、2010〜2017年)
  • 市場収益実績値(ブラジル、2003〜2010年)
  • 市場収益予測値(ブラジル、2010〜2017年)

第7章 戦略的競合企業評価

  • 企業シェア(全世界、2010年)
  • 市場機会とリスク評価
    • 機会評価
    • リスク評価
  • 主な企業
    • Hospira Inc.
    • CareFusion Corporation
    • Baxter International, Inc.
    • Medtronic, Inc

第8章 戦略的パイプライン評価

  • 認証段階にある輸液システム(全5種)
  • 治験段階にある輸液システム(全6種)
  • 初期開発段階にある輸液システム(全4種)
  • 前臨床段階にある輸液システム(全3種)

第9章 戦略的取引分析

  • 企業買収(2008年〜2011年)
  • ベンチャーファイナス融資(2008年〜2011年)
  • パートナーシップ(2008年〜2011年)
  • 株式発行(2008年〜2011年)
  • 社債発行(2008年〜2011年)
  • 資産取引(2008年〜2011年)
  • 未公開株取引(2008年〜2011年)
  • 主な取引

第10章 付録

図表一覧

目次

Summary

GlobalData's new report, "Infusion Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global infusion systems market. The report provides market landscape, competitive landscape and market trends information on the infusion systems market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market's dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • Key segments covered include Ambulatory Infusion Pumps, Implantable Infusion Pumps, Infusion Disposable Sets, Syringe Pumps and Volumetric Pumps.
  • Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
  • Qualitative analysis of key market trends, market drivers, and restraints within the infusion systems market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include Hospira, CareFusion Corporation, Baxter International and Medtronic.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the infusion systems globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What's the next big thing in the infusion systems market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global infusion systems market and the factors shaping it.

Table of Contents

1 Table of Contents 3

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Infusion Systems, Market Segmentation 8
  • 2.2 GlobalData Report Guidance 9

3 Device Overview - Infusion Systems 10

  • 3.1 Ambulatory Infusion Pumps 10
    • 3.1.1 Disposable Ambulatory Pumps 10
    • 3.1.2 Reusable Ambulatory Pumps 10
  • 3.2 Implantable Infusion Pumps 10
  • 3.3 Infusion Disposable Sets 11
  • 3.4 Syringe Pumps 11
    • 3.4.1 Patient Controlled Analgesia (PCA) Syringe Pumps 11
    • 3.4.2 Standard Syringe Pumps 11
  • 3.5 Volumetric Pumps 11

4 Global Market Characterization - Infusion Systems 12

  • 4.1 Infusion Systems Market, Global, Revenue ($m), Historic, 2003 - 2010 12
  • 4.2 Infusion Systems Market, Global, Revenue ($m), Forecast, 2010 - 2017 13
  • 4.3 Infusion Systems Market, Key Trends 14
    • 4.3.1 Growth in Home Based Infusion Therapy, Due to Improvement in Reimbursement Scenario and Market Conditions, can drive the Growth of the Infusion Systems Market 14
    • 4.3.2 The U.S. FDA's Initiative to Reduce Risks Related with Infusion Systems Usage Might Change the Market Dynamics for Infusion Systems 15
  • 4.4 Global Infusion Systems, Market Dynamics 15
    • 4.4.1 Market Drivers 16
    • 4.4.2 Market Restraints 23

5 Infusion Systems, Analysis by Segment, Revenue($m), 2003 - 2017 28

  • 5.1 Ambulatory Infusion Pumps Market, Global, Revenue ($m), Historic, 2003 - 2010 28
  • 5.2 Ambulatory Infusion Pumps Market, Global, Revenue ($m), Forecast, 2010 - 2017 29
  • 5.3 Implantable Infusion Pumps Market, Global, Revenue ($m), Historic, 2003 - 2010 30
  • 5.4 Implantable Infusion Pumps Market, Global, Revenue ($m), Forecast, 2010 - 2017 31
  • 5.5 Syringe Pumps Market, Global, Revenue ($m), Historic, 2003 - 2010 32
  • 5.6 Syringe Pumps Market, Global, Revenue ($m), Forecast, 2010 - 2017 33
  • 5.7 Volumetric Pumps Market, Global, Revenue ($m), Historic, 2003 - 2010 34
  • 5.8 Volumetric Pumps Market, Global, Revenue ($m), Forecast, 2010 - 2017 35

6 Infusion Systems, Analysis by Country, Revenue ($m), 2003 - 2017 36

  • 6.1 Infusion Systems Market, the US, Revenue ($m), Historic, 2003-2010 36
  • 6.2 Infusion Systems Market, the US, Revenue ($m), Forecast, 2010-2017 37
  • 6.3 Infusion Systems Market, Canada, Revenue ($m), Historic, 2003-2010 38
  • 6.4 Infusion Systems Market, Canada, Revenue ($m), Forecast, 2010-2017 39
  • 6.5 Infusion Systems Market, the UK, Revenue ($m), Historic, 2003-2010 40
  • 6.6 Infusion Systems Market, the UK, Revenue ($m), Forecast, 2010-2017 41
  • 6.7 Infusion Systems Market, Germany, Revenue ($m), Historic, 2003-2010 42
  • 6.8 Infusion Systems Market, Germany, Revenue ($m), Forecast, 2010-2017 43
  • 6.9 Infusion Systems Market, France, Revenue ($m), Historic, 2003-2010 44
  • 6.10 Infusion Systems Market, France, Revenue ($m), Forecast, 2010-2017 45
  • 6.11 Infusion Systems Market, Italy, Revenue ($m), Historic, 2003-2010 46
  • 6.12 Infusion Systems Market, Italy, Revenue ($m), Forecast, 2010-2017 47
  • 6.13 Infusion Systems Market, Spain, Revenue ($m), Historic, 2003-2010 48
  • 6.14 Infusion Systems Market, Spain, Revenue ($m), Forecast, 2010-2017 49
  • 6.15 Infusion Systems Market, Japan, Revenue ($m), Historic, 2003-2010 50
  • 6.16 Infusion Systems Market, Japan, Revenue ($m), Forecast, 2010-2017 51
  • 6.17 Infusion Systems Market, China, Revenue ($m), Historic, 2003-2010 52
  • 6.18 Infusion Systems Market, China, Revenue ($m), Forecast, 2010-2017 53
  • 6.19 Infusion Systems Market, India, Revenue ($m), Historic, 2003-2010 54
  • 6.20 Infusion Systems Market, India, Revenue ($m), Forecast, 2010-2017 55
  • 6.21 Infusion Systems Market, Australia, Revenue ($m), Historic, 2003-2010 56
  • 6.22 Infusion Systems Market, Australia, Revenue ($m), Forecast, 2010-2017 57
  • 6.23 Infusion Systems Market, Brazil, Revenue ($m), Historic, 2003-2010 58
  • 6.24 Infusion Systems Market, Brazil, Revenue ($m), Forecast, 2010-2017 59

7 Strategic Competitive Assessment - Infusion Systems 60

  • 7.1 Infusion Systems Market, Global, Company Share (%), 2010 60
  • 7.2 Infusion Systems, Market Opportunities and Risk Evaluation 61
    • 7.2.1 Opportunities Assessment 61
    • 7.2.2 Risk Evaluation 62
  • 7.3 Infusion Systems, Key Market Participants 62
    • 7.3.1 Hospira Inc. 62
    • 7.3.2 CareFusion Corporation 66
    • 7.3.3 Baxter International, Inc. 68
    • 7.3.4 Medtronic, Inc. 70

8 Strategic Pipeline Assessment - Infusion Systems 73

  • 8.1 Infusion Systems in Approval Phase 74
    • 8.1.1 Symbiq Infusion System Version 3.11, Hospira, Inc. 74
    • 8.1.2 Iluvien Injection System, pSivida Limited and Alimera Sciences, Inc. 74
    • 8.1.3 Medfusion 4000 Syringe Infusion Pump, Smiths Medical 75
    • 8.1.4 Micro-Infusion GnRH Pump, MicroPort Scientific Corporation 75
    • 8.1.5 CADD-Solis VIP Ambulatory Pump, Smiths Medical 75
  • 8.2 Infusion Systems in Clinical Development Stage 76
    • 8.2.1 ALN-HTT Infusion System, Medtronic, Inc. and Alnylam Pharmaceuticals, Inc 76
    • 8.2.2 AutoHep System, Automedics Medical Systems 77
    • 8.2.3 SABER Delivery System, DURECT Corporation 77
    • 8.2.4 Fluidnet System, Fluidnet Corporation 79
    • 8.2.5 Iject Pre-Filled Syringe, Bioject Medical Technologies 80
    • 8.2.6 Prometra Programmable Pump, Medasys, Inc. 80
  • 8.3 Infusion Systems in Early Development Stage 82
    • 8.3.1 Delpor Microfabricated Nanopore Device, Delpor, Inc. 82
    • 8.3.2 PRIDE System, PRO-IV Medical Ltd. 82
    • 8.3.3 NuPrivo - CI, Ratio, Inc. 83
    • 8.3.4 Drug Delivery System - Parkinson's Disease, Medtronic, Inc. and Eli Lilly and Company 83
  • 8.4 Infusion Systems in Pre Clinical Development Stage 83
    • 8.4.1 Biosilicon, pSivida Limited 84
    • 8.4.2 Medallion System, Advanced Bionics, LLC 84
    • 8.4.3 Nano Precision Pump, Nano Precision Medical 84

9 Strategic Deals Analysis - Infusion Systems 85

  • 9.1 Infusion Systems Market, Acquisitions, 2008-2011* 86
  • 9.2 Infusion Systems Market, Venture Financing Deals, 2008 - 2011* 87
  • 9.3 Infusion Systems Market, Partnerships, 2008-2011* 88
  • 9.4 Infusion Systems Market, Equity Offering Deals, 2008-2011* 89
  • 9.5 Infusion Systems Market, Debt Offering Deals, 2008-2011* 89
  • 9.6 Infusion Systems Market, Asset Transaction Deals, 2008-2011* 90
  • 9.7 Infusion Systems Market, Private Equity Deals, 2008-2011* 90
  • 9.8 Key Deals 91
    • 9.8.1 Baxter International Completes Acquisition of Baxa for $380m 91
    • 9.8.2 CarePoint Partners Acquires Premier Infusion 91
    • 9.8.3 Mindray Medical International to Acquire Controlling Stake in Shenzhen Shenke Medical Instrument 92

10 Appendix 93

  • 10.1 Market Definitions 93
    • 10.1.1 Infusion Systems 93
  • 10.2 Acronyms 94
  • 10.3 Research Methodology 96
    • 10.3.1 Secondary Research 96
    • 10.3.2 Primary Research 96
    • 10.3.3 Models 97
    • 10.3.4 Forecasts 97
    • 10.3.5 Expert Panels 97
  • 10.4 GlobalData Consulting 97
  • 10.5 Contact Us 97
  • 10.6 Disclaimer 98
  • 10.7 Sources 98

List of Tables

  • Table 1: Infusion Systems Market, Global, Revenue ($m), 2003 - 2010 12
  • Table 2: Infusion Systems Market, Global, Revenue ($m), 2010 - 2017 13
  • Table 3: Smart Pump, by Company, 2011 16
  • Table 4: Studies Proving Smart Infusion Pumps Effectiveness 17
  • Table 5: Percentage of People Aged 65 Years and Above, by Country, 2005 - 2015 19
  • Table 6: Medicare Reimbursement Codes For Various Infusion System Related Procedures 20
  • Table 7: Product Recall, Infusion Systems, the US, 2011 26
  • Table 8: Ambulatory Infusion Pumps Market, Global, Revenue ($m), 2003 - 2010 28
  • Table 9: Ambulatory Infusion Pumps Market, Global, Revenue ($m), 2010 - 2017 29
  • Table 10: Implantable Infusion Pumps Market, Global, Revenue ($m), 2003 - 2010 30
  • Table 11: Implantable Infusion Pumps Market, Global, Revenue ($m), 2010 - 2017 31
  • Table 12: Syringe Pumps Market, Global, Revenue ($m), 2003 - 2010 32
  • Table 13: Syringe Pumps Market, Global, Revenue ($m), 2010 - 2017 33
  • Table 14: Volumetric Pumps Market, Global, Revenue ($m), 2003 - 2010 34
  • Table 15: Volumetric Pumps Market, Global, Revenue ($m), 2010 - 2017 35
  • Table 16: Infusion Systems Market, the US, Revenue ($m), 2003-2010 36
  • Table 17: Infusion Systems Market, the US, Revenue ($m), 2010-2017 37
  • Table 18: Infusion Systems Market, Canada, Revenue ($m), 2003-2010 38
  • Table 19: Infusion Systems Market, Canada, Revenue ($m), 2010-2017 39
  • Table 20: Infusion Systems Market, the UK, Revenue ($m), 2003-2010 40
  • Table 21: Infusion Systems Market, the UK, Revenue ($m), 2010-2017 41
  • Table 22: Infusion Systems Market, Germany, Revenue ($m), 2003-2010 42
  • Table 23: Infusion Systems Market, Germany, Revenue ($m), 2010-2017 43
  • Table 24: Infusion Systems Market, France, Revenue ($m), 2003-2010 44
  • Table 25: Infusion Systems Market, France, Revenue ($m), 2010-2017 45
  • Table 26: Infusion Systems Market, Italy, Revenue ($m), 2003-2010 46
  • Table 27: Infusion Systems Market, Italy, Revenue ($m), 2010-2017 47
  • Table 28: Infusion Systems Market, Spain, Revenue ($m), 2003-2010 48
  • Table 29: Infusion Systems Market, Spain, Revenue ($m), 2010-2017 49
  • Table 30: Infusion Systems Market, Japan, Revenue ($m), 2003-2010 50
  • Table 31: Infusion Systems Market, Japan, Revenue ($m), 2010-2017 51
  • Table 32: Infusion Systems Market, China, Revenue ($m), 2003-2010 52
  • Table 33: Infusion Systems Market, China, Revenue ($m), 2010-2017 53
  • Table 34: Infusion Systems Market, India, Revenue ($m), 2003-2010 54
  • Table 35: Infusion Systems Market, India, Revenue ($m), 2010-2017 55
  • Table 36: Infusion Systems Market, Australia, Revenue ($m), 2003-2010 56
  • Table 37: Infusion Systems Market, Australia, Revenue ($m), 2010-2017 57
  • Table 38: Infusion Systems Market, Brazil, Revenue ($m), 2003-2010 58
  • Table 39: Infusion Systems Market, Brazil, Revenue ($m), 2010-2017 59
  • Table 40: Infusion Systems Market, Global, Company Share (%), 2010 60
  • Table 41: Hospira, Key Products, 2011 63
  • Table 42: Hospira, Sales ($m), the US vs EMEA vs APAC, 2008-2010 65
  • Table 43: CareFusion, Key Products, 2011 66
  • Table 44: Baxter, Key Products, 2011 68
  • Table 45: Baxter, Infusion Pump Revenues ($m), 2008-2010 70
  • Table 46: Medtronic, Key Products, 2011 71
  • Table 47: Infusion Systems, Global Pipeline Products, 2011 73
  • Table 48: List of Infusion Systems in Approval Process 74
  • Table 49: Symbiq Infusion System Version 3.11, Status 74
  • Table 50: Iluvien Injection System, Status 74
  • Table 51: Medfusion 4000 Syringe Infusion Pump, Status 75
  • Table 52: Micro-Infusion GnRH Pump, Status 75
  • Table 53: CADD-Solis VIP Ambulatory Pump, Status 76
  • Table 54: List of Infusion Systems in Clinical Development Stage 76
  • Table 55: ALN-HTT Infusion System, Status 76
  • Table 56: AutoHep System, Status 77
  • Table 57: SABER Delivery System, Status 77
  • Table 58: SABER Delivery System, Clinical Trial I 78
  • Table 59: SABER Delivery System, Clinical Trial II 79
  • Table 60: Fluidnet System, Status 79
  • Table 61: Iject Pre-Filled Syringe, Status 80
  • Table 62: Prometra Programmable Pump, Product Status 80
  • Table 63: Prometra Implantable Programmable Pump (PUMP), Clinical Trial 81
  • Table 64: List of Infusion Systems in Early Development Stage 82
  • Table 65: Delpor Microfabricated Nanopore Device, Status 82
  • Table 66: PRIDE System, Status 82
  • Table 67: NuPrivo - CI, Status 83
  • Table 68: Drug Delivery System - Parkinson's Disease, Status 83
  • Table 69: List of Infusion Systems in Pre-Clinical Stage 83
  • Table 70: Biosilicon, Status 84
  • Table 71: Medallion System, Status 84
  • Table 72: Nano Precision Pump, Status 84
  • Table 73: Infusion Systems Market, Deals, 2008-2011* 85
  • Table 74: Infusion Systems Market, Acquisitions, 2008-2011* 86
  • Table 75: Infusion Systems Market, Venture Financing Deals, 2008 - 2011* 87
  • Table 76: Infusion Systems Market, Partnerships, 2008-2011* 88
  • Table 77: Infusion Systems Market, Equity Offering Deals, 2008-2011* 89
  • Table 78: Infusion Systems Market, Debt Offering Deals, 2008-2011* 89
  • Table 79: Infusion Systems Market, Asset Transaction Deals, 2008-2011* 90
  • Table 80: Infusion Systems Market, Private Equity Deals, 2008-2011* 90

List of Figures

  • Figure 1: Infusion Systems, Market Segmentation 8
  • Figure 2: Infusion Systems Market, Global, Revenue ($m), 2003 - 2010 12
  • Figure 3: Infusion Systems Market, Global, Revenue ($m), 2010 - 2017 13
  • Figure 4: Global Infusion Systems, Market Dynamics 15
  • Figure 5: Percentage of People Aged 65 Years and Above, by Country, 2005 - 2015 19
  • Figure 6: Chronology of Developments in Area of Home Infusion Therapy, the US 22
  • Figure 7: Nursing Shortage, Global, 2008-2012 23
  • Figure 8: Barriers in Adaptation of Smart Pump Technology 24
  • Figure 9: Ambulatory Infusion Pumps Market, Global, Revenue ($m), 2003 - 2010 28
  • Figure 10: Ambulatory Infusion Pumps Market, Global, Revenue ($m), 2010 - 2017 29
  • Figure 11: Implantable Infusion Pumps Market, Global, Revenue ($m), 2003 - 2010 30
  • Figure 12: Implantable Infusion Pumps Market, Global, Revenue ($m), 2010 - 2017 31
  • Figure 13: Syringe Pumps Market, Global, Revenue ($m), 2003 - 2010 32
  • Figure 14: Syringe Pumps Market, Global, Revenue ($m), 2010 - 2017 33
  • Figure 15: Volumetric Pumps Market, Global, Revenue ($m), 2003 - 2010 34
  • Figure 16: Volumetric Pumps Market, Global, Revenue ($m), 2010 - 2017 35
  • Figure 17: Infusion Systems Market, the US, Revenue ($m), 2003-2010 36
  • Figure 18: Infusion Systems Market, the US, Revenue ($m), 2010-2017 37
  • Figure 19: Infusion Systems Market, Canada, Revenue ($m), 2003-2010 38
  • Figure 20: Infusion Systems Market, Canada, Revenue ($m), 2010-2017 39
  • Figure 21: Infusion Systems Market, the UK, Revenue ($m), 2003-2010 40
  • Figure 22: Infusion Systems Market, the UK, Revenue ($m), 2010-2017 41
  • Figure 23: Infusion Systems Market, Germany, Revenue ($m), 2003-2010 42
  • Figure 24: Infusion Systems Market, Germany, Revenue ($m), 2010-2017 43
  • Figure 25: Infusion Systems Market, France, Revenue ($m), 2003-2010 44
  • Figure 26: Infusion Systems Market, France, Revenue ($m), 2010-2017 45
  • Figure 27: Infusion Systems Market, Italy, Revenue ($m), 2003-2010 46
  • Figure 28: Infusion Systems Market, Italy, Revenue ($m), 2010-2017 47
  • Figure 29: Infusion Systems Market, Spain, Revenue ($m), 2003-2010 48
  • Figure 30: Infusion Systems Market, Spain, Revenue ($m), 2010-2017 49
  • Figure 31: Infusion Systems Market, Japan, Revenue ($m), 2003-2010 50
  • Figure 32: Infusion Systems Market, Japan, Revenue ($m), 2010-2017 51
  • Figure 33: Infusion Systems Market, China, Revenue ($m), 2003-2010 52
  • Figure 34: Infusion Systems Market, China, Revenue ($m), 2010-2017 53
  • Figure 35: Infusion Systems Market, India, Revenue ($m), 2003-2010 54
  • Figure 36: Infusion Systems Market, India, Revenue ($m), 2010-2017 55
  • Figure 37: Infusion Systems Market, Australia, Revenue ($m), 2003-2010 56
  • Figure 38: Infusion Systems Market, Australia, Revenue ($m), 2010-2017 57
  • Figure 39: Infusion Systems Market, Brazil, Revenue ($m), 2003-2010 58
  • Figure 40: Infusion Systems Market, Brazil, Revenue ($m), 2010-2017 59
  • Figure 41: Infusion Systems Market, Global, Company Share (%), 2010 60
  • Figure 42: Infusion Systems, Market Opportunities and Risk Evaluation 61
  • Figure 43: Hospira Inc., Internal Factors Evaluation 63
  • Figure 44: Hospira, Net Sales of Infusion Pumps, the US vs. Outside the US, 2004 - 2010 64
  • Figure 45: Hospira, Sales ($m), the US vs EMEA vs APAC, 2008-2010 65
  • Figure 46: CareFusion, Internal Factors Evaluation 67
  • Figure 47: Baxter, Internal Factors Evaluation 68
  • Figure 48: Baxter, Infusion Pump Revenues ($m), 2008-2010 69
  • Figure 49: Medtronic, Internal Factors Evaluation 71
  • Figure 50: Infusion Systems, Global Pipeline Products, 2011 73
  • Figure 51: Infusion Systems Market, Deals, 2008-2011* 85
Back to Top